Synthetic Biologics Inc (SYN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SYN | AMGN | VRTX | REGN | GILD |
| Company | Synthetic Biologics Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NYSE Arca | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.0200 | 313.34 | 467.94 | 1,047.11 | 68.63 |
| High | 1.0200 | 319.00 | 478.96 | 1,069.69 | 69.99 |
| Low | 0.9700 | 310.23 | 467.86 | 1,045.00 | 68.50 |
| Last | 1.0200 | 311.01 | 471.25 | 1,057.02 | 68.64 |
| Change | +0.0100 | -1.44 | +2.53 | +5.99 | +0.03 |
| % Change | +0.99% | -0.46% | +0.54% | +0.57% | +0.04% |
| Volume | 57,700 | 1,768,600 | 950,400 | 383,100 | 5,246,300 |
| 20-Day Average Volume | 49,125 | 2,477,470 | 1,338,860 | 484,645 | 9,513,595 |
| Previous Close | 1.0100 | 312.45 | 468.72 | 1,051.03 | 68.61 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.1113 | 307.56 | 475.67 | 1,032.03 | 66.27 |
| 20-Day Raw Stochastic | 11.63% | 50.97% | 53.59% | 76.30% | 62.72% |
| 20-Day Relative Strength | 34.20% | 56.09% | 59.22% | 66.42% | 55.44% |
| Weighted Alpha | -82.00 | +36.50 | +40.67 | +49.78 | -9.98 |
| Today's Opinion | 100% Sell | 100% Buy | 88% Buy | 100% Buy | 40% Sell |
| Previous Opinion | 100% Sell | 100% Buy | 88% Buy | 100% Buy | 56% Sell |
| Last Month's Opinion | 100% Sell | 72% Buy | 88% Buy | 72% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -11.30% since 10/05/22 | -2.24% since 06/24/24 | -0.78% since 06/24/24 | -0.65% since 06/24/24 | -2.95% since 06/24/24 |
| Low | 0.9700 on 10/12/22 | 310.23 on 07/01/24 | 467.67 on 06/28/24 | 1,041.78 on 06/28/24 | 68.06 on 06/28/24 |
| High | 1.1900 on 10/06/22 | 326.12 on 06/25/24 | 483.92 on 06/25/24 | 1,081.17 on 06/25/24 | 71.48 on 06/25/24 |
| 1-Month | |||||
| %Chg | -28.17% since 09/12/22 | +1.69% since 05/31/24 | +3.49% since 05/31/24 | +7.84% since 05/31/24 | +6.80% since 05/31/24 |
| Low | 0.9700 on 10/12/22 | 295.30 on 06/13/24 | 453.73 on 06/03/24 | 979.26 on 06/03/24 | 62.69 on 06/18/24 |
| High | 1.4700 on 09/13/22 | 326.12 on 06/25/24 | 486.42 on 06/07/24 | 1,081.17 on 06/25/24 | 72.18 on 06/21/24 |
| 3-Month | |||||
| %Chg | -57.07% since 07/12/22 | +9.88% since 04/01/24 | +12.07% since 04/01/24 | +9.05% since 04/01/24 | -5.82% since 04/01/24 |
| Low | 0.9700 on 10/12/22 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
| High | 2.3990 on 07/13/22 | 326.12 on 06/25/24 | 486.42 on 06/07/24 | 1,081.17 on 06/25/24 | 72.85 on 04/02/24 |
| 6-Month | |||||
| %Chg | -60.90% since 04/12/22 | +7.98% since 12/29/23 | +15.82% since 12/29/23 | +20.35% since 12/29/23 | -15.27% since 12/29/23 |
| Low | 0.9700 on 10/12/22 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 871.39 on 01/02/24 | 62.07 on 05/31/24 |
| High | 2.6900 on 04/13/22 | 329.72 on 02/05/24 | 486.42 on 06/07/24 | 1,081.17 on 06/25/24 | 87.86 on 01/19/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 16,161 | 167,609,120 | 120,954,608 | 115,808,784 | 85,477,984 |
| Shares Outstanding, K | 15,844 | 536,435 | 258,053 | 110,186 | 1,245,853 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 27,116,000,000 |
| Annual Net Income | -14,270,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 5,665,000,000 |
| Last Quarter Sales | 0 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 6,686,000,000 |
| Last Quarter Net Income | -4,968,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | -4,170,000,000 |
| 60-Month Beta | 1.38 | 0.60 | 0.41 | 0.13 | 0.20 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.31 on 08/11/22 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -1.32 on 04/25/24 |
| Latest Earnings Date | 11/02/22 | 08/01/24 | 08/06/24 | 08/01/24 | 08/01/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.770 on 06/14/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 06/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.84 | 31.38 | 28.32 | 17.08 |